ArticleThoracic cancer2023

First case report of erlotinib plus ramucirumab treatment for lung carcinosarcoma with EGFR L858R mutation.

Naoya Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.